Camber Capital Management LP - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 154 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
Camber Capital Management LP ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$82,532,000
+145.7%
8,780,000
+100.0%
2.18%
+13.3%
Q2 2020$33,584,000
+23.8%
4,390,0000.0%1.92%
+18.6%
Q1 2020$27,130,000
-49.2%
4,390,0000.0%1.62%
-40.4%
Q4 2019$53,426,000
+5.4%
4,390,0000.0%2.72%
+2.0%
Q3 2019$50,705,000
+69.2%
4,390,000
+46.3%
2.67%
+90.8%
Q2 2019$29,970,000
-12.2%
3,000,000
+13.2%
1.40%
-17.9%
Q1 2019$34,132,000
-15.2%
2,650,0000.0%1.70%
-10.9%
Q4 2018$40,254,000
-24.0%
2,650,0000.0%1.91%
-15.8%
Q3 2018$53,000,000
+2.6%
2,650,0000.0%2.27%
+14.1%
Q2 2018$51,675,000
-3.2%
2,650,0000.0%1.99%
-24.2%
Q1 2018$53,398,000
+52.1%
2,650,0000.0%2.62%
+52.5%
Q4 2017$35,113,000
-28.2%
2,650,0000.0%1.72%
-44.5%
Q3 2017$48,893,000
+56.3%
2,650,000
+55.9%
3.10%
+103.5%
Q2 2017$31,280,000
+47.0%
1,700,000
+178.1%
1.52%
+37.5%
Q4 2016$21,276,000
+42.0%
611,3900.0%1.11%
+68.1%
Q3 2016$14,985,000
+4.4%
611,390
+1.9%
0.66%
-5.0%
Q2 2016$14,352,000
+2.2%
600,0000.0%0.69%
-15.6%
Q1 2016$14,040,000
-74.8%
600,000
-41.1%
0.82%
-79.3%
Q1 2015$55,657,000
+30.6%
1,018,246
+1.8%
3.97%
+40.2%
Q4 2014$42,620,000
+78.1%
1,000,000
+33.3%
2.83%
+26.0%
Q3 2014$23,932,000750,0002.25%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
HealthInvest Partners AB 520,000$15,699,0007.39%
Palo Alto Investors LP 2,835,792$85,613,0004.76%
Opaleye Management Inc. 150,000$4,529,0001.89%
Engaged Capital LLC 61,425$1,854,0001.15%
IRONWOOD INVESTMENT MANAGEMENT LLC 91,400$2,759,0001.14%
Endurant Capital Management LP 111,180$3,357,0001.12%
AlphaOne Investment Services, LLC 86,817$2,621,0000.94%
ASHFORD CAPITAL MANAGEMENT INC 127,625$3,853,0000.91%
ARDSLEY ADVISORY PARTNERS LP 205,000$6,189,0000.81%
STELLIAM INVESTMENT MANAGEMENT, LP 685,000$20,680,0000.62%
View complete list of AMAG PHARMACEUTICALS INC shareholders